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The CAMP-dependent protein kinase from LLC-PK, cells can be activated in vivo by calcitonin and vaso- 
pressin, or forskolin. Continuous treatment of cells with these agents results in a decrease of total CAMP-PK 
activity. The loss of kinase activity was enhanced when either of these three agents was incubated in the 
presence of isobutylmethylxanthine. Results obtained using affinity purified antibodies to the catalytic sub- 
unit show that the loss of kinase was due to specific proteolysis of this subunit. 
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1. INTRODUCTION 
Hormonal regulation of cellular function 
through alterations of intracellular levels of CAMP 
is a basic control mechanism of all mammalian 
cells [l]. All the data so far available suggest hat 
the CAMP-dependent protein kinase (CAMP-PK) 
mediates all the known effects of CAMP [2]. The 
holoenzyme of the CAMP-PK is a catalytically in- 
active tetramer composed of 2 regulatory (R) and 
2 catalytic (C) subunits [3]. The R subunits bind 2 
molecules of CAMP per monomer which results in 
the release of the catalytically active C subunits [4]. 
Two major classes (designated type I and II) of 
CAMP-PK are present in most mammalian cells, 
which have different R subunits but apparently 
identical C subunits [3]. 
Although the short-term effects of CAMP on the 
regulation of CAMP-PK have been intensively 
studied, very little information is known about the 
control mechanisms which modulate the total 
levels of either the type I or II kinase [5]. The 
amounts of type I and type II kinase synthesized in 
various tissues are different suggesting that the 2 
isoenzymes have different biological functions. 
This hypothesis is supported by the fact that the 
ratio of type I and type II CAMP-PK changes in a 
number of cell lines during differentiation [5]. 
In this communication an additional in vivo 
mechanism for regulating the CAMP-PK is de- 
scribed. Long-term exposure to high levels of 
CAMP was found to result in a loss of kinase ac- 
tivity, which was apparently due to a decrease of C 
subunit protein. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Porcine epithelial cells, LLC-PKI, were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) fetal calf serum at 
37°C. Prior to hormone treatment or addition of 
drugs monolayer cultures were washed with 
DMEM (serum free) and then incubated in DMEM 
containing hormone or drug at 37°C. 
2.2. Enzyme assays 
The CAMP-PK was assayed using the synthetic 
peptide, Leu-Arg-Arg-Ala-Ser-Ala-Gly as sub- 
strate essentially as described in [6]. Protein kinase 
activity is expressed as units per mg protein (1 unit 
kinase activity is defined as the amount of enzyme 
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which catalyzes the transfer of 1 nmol phosphate 
from ATP to the peptide per min). CAMP binding 
activity was measured using the method of Gilman 
[7]. Protein concentrations were measured accord- 
ing to Bradford [8] with bovine serum albumin as 
standard. 
Cell-free extracts were prepared in 20 mM Mes- 
NaOH, pH 6.8, containing 150 mM NaCl, 1 mM 
EDTA and 0.2% (v/v) Triton X-100. For the 
CAMP binding assay the Triton X-100 was 
omitted. 
2.3. Purification of CAMP-PK 
The C and R subunits of CAMP-PK were 
purified from bovine heart or skeletal muscle ac- 
cording to Beavo et al. [9]. 
2.4. Preparation of antibodies specific for RI, RII 
and C subunits of CAMP-PK 
Purified subunits were cross linked to keyhole 
limpet hemocyanin according to Schwoch et al. 
[lo] prior to injection into rabbits. Antisera were 
purified by (NH&S04 fractionation and 
chromatography on antigen-agarose columns. 
2.5. Immunoblot analysis 
Slab gel electrophoresis was performed on 10% 
separating gels in the presence of 0.1% SDS 
following the method of Laemmli [l 11. The pro- 
teins were electrophoretically transferred to a 
nitrocellulose filter at 60 V for 3-4 h as described 
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Fig. 1. Effect of calcitonin in the presence or absence of 
IBMX on the total catalytic activity (a), activity ratio (b) 
and CAMP-binding (c), of the CAMP-PK from LLC-PKi 
cells. Cells were grown to 80% confluency in DMEM 
containing 10% (v/v) fetal calf serum. At the start of the 
experiment he cells were washed 3 times with DMEM 
and then incubated at 37°C in DMEM containing 
10T8 M calcitonin (=) or 10m8 M calcitonin plus 0.5 mM 
IBMX (0). The control (0) was incubated in DMEM 
without any additions. At the times indicated cell free 
extracts were prepared and assayed for C and R subunits 
and the kinase activity ratio. 
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by Towbin et al. [ 121. After transfer, nitrocellulose 
sheets were blocked using 3% (w/v) bovine serum 
albumin, 3Yo (w/v) ovalbumin and 1% (w/v) 
gelatin for 1 h. The proteins were visualized using 
the specific affinity purified antisera and “‘I- 
labeled protein A. 
2.6. Materials 
Dulbecco’s modified Eagle’s medium was from 
Gibco; fetal calf serum from Flow Laboratories; 
synthetic salmon calcitonin was a gift of Armour 
Pharmaceutical; dexamethasone was obtained 
from Sigma and [argininel-vasopressin was pur- 
chased from Peninsula. Isobutylmethylxanthine, 
Kemptide, ATP, CAMP and Triton X-100 were 
from Sigma. [32P]ATP and [3H]cAMP and ‘*sI- 
protein A were obtained from Amersham. 
Phosphocellulose paper (P-81) was obtained from 
Whatman and nitrocellulose from Schleicher and 
&hull. 
3. RESULTS 
3.1. Long treatment of LLC-PK, cells with agents 
that elevate CAMP levels 
Previously it was demonstrated that the addition 
of calcitonin, vasopressin or forskoIin to 
monolayer cultures of LLC-PKr cells promoted a 
partial activation of the CAMP-PK which could be 
enhanced by the addition of IBMX to the culture 
medium ([13,14] also see fig. lb). These studies on 
the regulation of CAMP-PK in LLC-PKr cells have 
been extended to investigate the effect of long-term 
exposure of cells to hormones, forskolin and 
8-bromo CAMP (BrcAMP). The data presented in 
table 1 show that treatment for 24 h of LLC-PKr 
cells with hormones, forskolin or BrcAMP 
resulted in a 20-40% decrease of total CAMP-PK 
activity. The simultaneous addition of IBMX 
(0.5 mM) with these compounds resulted in a 70% 
decrease of total CAMP-PK activity. The addition 
of dexamethasone, a steroid hormone which is 
known to modulate CAMP action in LLC-PKI cells 
[13], had no effect on the loss of C subunit activity 
(table 1). 
The activity ratio of the CAMP-PK (the level of 
free C subunit relative to total CAMP-PK activity), 
the loss of total kinase and R subunit levels were 
investigated in more detail following calcitonin 
treatment in the presence or absence of IBMX 
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Table 1 
Effect of various hormones and drugs on the in vivo 
stability of carp-dependent protein kinase 
Treatment CAMP-PK Vo 
activity decrease 
(units/mg 
protein) 
Expt I 
Control 
Dexamethasone (lo-’ M) 
Calcitonin (3 x IO-’ M) 
Dexamethasone ( 1O-7 M) 
plus calcitonin 
Calcitonin (3 x lOA M) 
plus IBMX (0.5 mM) 
Dexamethasone (lo-’ M), 
calcitonin (3 x lo”* M) 
and IBMX (0.5 mM) 
Expt II 
Control 
IBMX (0.5 mM) 
Args-vasopressin 
(3 x 1O-8 M) 
Arg’-vasopressin 
(3 x 1O-8 M) 
plus IBMX (0.5 mM) 
Forskolin (50 PM) 
Forskolin (50 ,uM) plus 
IBMX (0.5 mM) 
Expt III 
Control 
IBMX (0.5 mM) 
0.1 mM 8--BrcAMP 
0.1 mM 8-BrcAMP plus 
IBMX (0.5 mM) 
0.5 mM 8-BrcAMP 
0.5 mM 8-BrcAMP plus 
IBMX (0.5 mM) 
1.0 mM 8-BrcAMP 
1.0 mM 8-BrcAMP plus 
IBMX (0.5 mM) 
4.55 0 
4.06 11 
2.51 45 
2.49 45 
1.25 73 
1.18 74 
4.38 0 
2.70 38 
2.91 34 
1.48 
3.49 
1.26 
66 
20 
12 
4.63 
3.29 
3.76 
0 
29 
2.22 52 
2.93 36 
1.43 
2.14 
1.25 
69 
54 
73 
Monolayer cultures of LLC-PKt cells were grown to 
-80% of confluency, washed 3 x with prewarmed 
DMEM and then incubated at 37°C for 24 h in DMEM 
containing the indicated additions. Total CAMP-PK 
levels were determined as described in section 2. The 
above data are representative of several experiments that 
gave similar results 
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(fig.la and b). These data show 2 important 
aspects of this regulatory mechanism: (i) the loss of 
kinase is relatively rapid (fr,z 5 h) and (ii) follow- 
ing the initial activation of the CAMP-PK, during 
the first 3 h of hormone stimulation, the levels of 
free C subunit decline. This latter result suggests 
that the synthesis of CAMP was down regulated. 
Determination of total R subunit levels by the 
[3H]cAMP binding assay showed that the amount 
of CAMP binding activity remained relatively con- 
stant during the period when C subunit declined 
most rapidly (fig.lc). In fact, with the calcitonin 
treatment an increase of CAMP binding activity 
was observed. 
3.2. Investigations on the mechanism of loss of 
CAMP-PK activity 
Antibodies to purified bovine C, RI and Ru 
subunits were prepared in rabbits and used to 
quantitate CAMP-PK subunit levels, by Western 
blotting, during prolonged hormone treatment. 
The 3 antibody preparations were affinity purified 
on antigen-agarose columns and found to cross 
react with purified porcine C, RI and RII. 
Western blot analysis was used to quantitate C 
subunit levels following treatment with calcitonin 
plus or minus IBMX (fig.2). This analysis revealed 
that the levels of immunoreactive protein declined 
in parallel with the loss of kinase activity. After 
12.5 h of treatment only -25% of C subunit pro- 
tein remained as judged by densitometric 
quantitation. 
Fig.2. Determination of catalytic subunit levels in cell 
extracts following calcitonin treatment (in the presence 
or absence of IBMX). Cells were grown and treated as 
indicated in fig. 1. Lane 1: 90 ng purified bovine skeletal 
muscle C subunit. All other lanes contain 225 pg cell 
extract. Lanes 2-4: control at 0, 6 and 12.5 h, 
respectively. Lanes 5-7: cells treated with calcitonin for 
3, 6 and 12.5 h, respectively. Lanes 8-10: cells treated 
with calcitonin for 3, 6 and 12.5 h, respectively. 
4. DISCUSSION 
The data presented show that the CAMP-PK 
from LLC-PKr cells is regulated by 2 different 
mechanisms, (i) through changes in intracellular 
CAMP levels and (ii) by specific proteolysis. 
In a previous publication [ 131 it was 
demonstrated that the activation (dissociation of 
the holoenzyme) and the inactivation (the 
reassociation of the R and C subunits) following 
hormone treatment are very rapid (tl/z for both 
processes of around 10 min), confirming that the 
activation state of CAMP-PK is rapidly responsive 
to fluctuations of CAMP levels caused by hor- 
monal stimulation. 
However, under conditions that lead to a long- 
term activation of CAMP-PK an additional control 
mechanism exists for regulating C subunit levels 
which involves proteolytic inactivation of this en- 
zyme. Under normal growth conditions, prior to 
hormonal stimulation, the CAMP-PK was main- 
tained predominantly in the holoenzyme form and 
not subject to proteolysis. Following the addition 
of hormones or compounds which elevate in- 
tracellular CAMP, free C subunit levels are in- 
creased to 100% of total C subunits, resulting in 
the loss of C subunit activity and immunoreactive 
protein. The R subunit did not appear to be rapidly 
degraded under these conditions. 
Recently Shaltiel and co-workers [14,15] have 
described a C subunit specific protease which 
cleaves the native C subunit, when it is dissociated 
from R, to produce an inactive enzyme of 37 kDa. 
Whether a similar protease as that described above 
is present in LLC-PKr cells is currently being in- 
vestigated. However, the immunoblot data suggest 
that a clipped form of the C subunit does not ac- 
cumulate in vivo. 
What is the physiological function of this con- 
trol mechanism? It is possible that it represents a 
safety control mechanism which would normally 
operate during the down regulation phase of the 
cellular response to hormone stimulation. Such a 
mechanism would reduce free C subunit levels 
which might otherwise be inhibitory to normal cell 
growth. Recently mutant LLC-PKr cells have been 
isolated which are not growth inhibited by CAMP 
(unpublished). The level of C subunit activity in 
these cells is around Yio of that in the parent 
strain. 
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